Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
VIVES Partners
WavreSeed–Growth$108K – $7.6M
5 people
FemHealth Ventures
Short HillsSeed–Series A
10 people
Germin8 Ventures
ChicagoSeed–Series B
9 people
LifeArc Ventures
LondonSeed–Series A
12 people
Santen Pharmaceutical
OsakaSeries A–Series C
24 people
Cowin Capital Group
ShenzhenSeed–Series A
11 people
FundWA
Mount PleasantSeed–Series A$200K – $1M
11 people
Nimbus Synergies Inc.
VancouverPre-Seed–Series A$250K – $2M
14 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Riverfront Ventures, LLC
PittsburghSeed–Series A$250K – $1M
8 people
Triatomic Capital
Palo AltoSeed–Series C$100K – $1M
8 people
Latterell Venture Partners
San RamonSeed–Series A$50K – $10M
6 people
Heran Partners
AntwerpSeed–Series B
13 people
Claris Ventures
TorinoSeed–Series A
14 people
Bootstrap Venture Partners
Solana BeachSeed–Series A
6 people
Impact India Investment Partners
MumbaiPre-Seed–Series A$150K – $1M
12 people
SBI Investment
TokyoPre-Seed–Growth
6 people
Übermorgen Ventures
ZurichPre-Seed–Series A$330K – $1.1M
6 people
KREAXI
LyonPre-Seed–Series A$110K – $2.2M
11 people
Pier 70 Ventures
SeattleSeed–Series A
17 people
Fast Track Initiative
TokyoPre-Seed–Growth
2 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people
Ideaspring Capital
BengaluruSeed–Series A$2M
7 people
Redesign Health
New YorkSeed–Late Stage
13 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.



























































































